Clinical Trial Update: A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART [Phase 3]

View source ↗

Summary

A Phase 3 randomized, multicenter, open-label, evaluator-blinded trial comparing Folitime (Gema Biotech S.A.) with Gonal-f (Merck Serono) in infertility patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Folitime
• Gonal-F (follitropin alfa)

Snippet

Sponsor: Gema Biotech S.A. | Conditions: Infertility | Phase 3 | Status: COMPLETED